Human leukemic cells: receptor binding and biological effects of insulin and insulin-like growth factors. 1986

U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller

Receptor binding and biological effects of insulin and insulin-like growth factors I and II (IGF I/II) were assessed in three human malignant cell lines: a Burkitt-type ALL-cell line, a ANLL-cell line and a Hodgkin's disease-cell line. Insulin receptor binding could be demonstrated in Burkitt-type ALL cells and ANLL cells, whereas no insulin receptor binding was detectable in Hodgkin cells. IGF I and IGF II binding could be demonstrated in all leukemic cells. Insulin stimulated glycogen synthesis in the insulin receptor bearing cell lines. DNA synthesis was stimulated by insulin, IGF I and II. IGF I was more active in stimulating DNA synthesis than IGF II.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006003 Glycogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013002 Somatomedins Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. Sulfation Factor,Somatomedin,Factor, Sulfation
D017451 Receptors, Somatomedin Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes. Receptors, Insulin-Like Growth Factors,Somatomedin Receptors,Insulin-Like Growth Factor Receptor,Insulin-Like Growth Factor Receptors,Somatomedin Receptor,Insulin Like Growth Factor Receptor,Insulin Like Growth Factor Receptors,Receptor, Somatomedin,Receptors, Insulin Like Growth Factors

Related Publications

U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
November 1987, Journal of cellular physiology,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
August 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
February 1995, Endocrine reviews,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
January 1981, European journal of biochemistry,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
May 1991, Diabetologia,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
June 1978, European journal of biochemistry,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
December 1984, Cancer research,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
January 1986, The Journal of clinical endocrinology and metabolism,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
January 1986, The Biochemical journal,
U Vetter, and J H Schlickenrieder, and J Zapf, and W Hartmann, and W Heit, and H Hitzler, and P Byrne, and G Gaedicke, and E Heinze, and W M Teller
December 2004, The Journal of endocrinology,
Copied contents to your clipboard!